WINNERS & LOSERS: Animalcare agrees to bid; Alumasc lowers forecast
16th Apr 2026 12:02
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More
| Price | 245.00p on 06-05-2026 at 07:03:20 |
|---|---|
| Change | 0.00p 0% |
| Buy | 250.00p |
| Sell | 240.00p |
| Last Trade: | Buy 181.00 at 248.90p |
| Day's Volume: | 950 |
| Last Close: | 245.00p |
| Open: | 245.00p |
| ISIN: | GB0000280353 |
| Day's Range | 245.00p - 245.00p |
| 52wk Range: | 207.50p - 395.00p |
| Market Capitalisation: | £88.10m |
| VWAP: | 246.91679p |
| Shares in Issue: | 35.96m |
Sector: Construction
Listed In: FTSE AIM All-Share,
Alumasc Group (ALU) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 181 | 248.90p | Ordinary |
08:03:19 - 06-May-26 |
| Buy* | 769 | 246.45p | Ordinary |
08:01:11 - 06-May-26 |
| Unknown* | 14,022 | 245.00p | Uncrossing Trade |
16:35:20 - 05-May-26 |
| Buy* | 10,000 | 245.00p | Ordinary |
15:54:41 - 05-May-26 |
| Sell* | 2,500 | 243.80p | Ordinary |
15:51:23 - 05-May-26 |
| Sell* | 18 | 243.75p | Ordinary |
14:22:08 - 05-May-26 |
| Sell* | 361 | 243.75p | Ordinary |
14:08:29 - 05-May-26 |
| Sell* | 700 | 243.70p | Ordinary |
13:01:34 - 05-May-26 |
| Sell* | 156 | 240.00p | Ordinary |
12:54:25 - 05-May-26 |
| Sell* | 922 | 243.70p | Ordinary |
12:44:20 - 05-May-26 |
Alumasc Group (ALU) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 21st Apr 2026 7:00 am | RNS | Director Dealings |
| 20th Apr 2026 2:37 pm | RNS | Holding(s) in Company |
| 16th Apr 2026 7:00 am | RNS | Q3 Trading Update |
| 1st Apr 2026 7:00 am | RNS | Confirmation of CEO appointment |
| 9th Feb 2026 7:00 am | RNS-R | MelloMonday Investor Webinar |
| 3rd Feb 2026 7:00 am | RNS | Interim Results |
| 15th Jan 2026 7:00 am | RNS | Directorate change |
| 10th Dec 2025 9:36 am | RNS | Notice of Half Year Results |
| 21st Nov 2025 2:17 pm | RNS | Director/PDMR Shareholding |
| 7th Nov 2025 11:22 am | RNS | Director/PDMR Shareholding |